Physician profile
Rigoberto Ramirez
NPI 1467742114
$32,269.14
in general payments reported to CMS, 2019-2025
27 companies · $11K in 2025
The $11K reported for 2025 was more than what 82% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,082 · 2020: $331 · 2021: $1,666 · 2022: $4,230 · 2023: $3,501 · 2024: $3,138 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,534 · Travel and Lodging: $4,527 · Consulting Fee: $3,900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,533.66 |
| Travel and Lodging | $4,526.94 |
| Consulting Fee | $3,900.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $9,420.89 | 2021-2025 | Cobalt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan, Evera Mri Xt Dr Surescan |
| Medtronic Vascular, INC. | $8,026.43 | 2019-2020 | |
| Boston Scientific Corporation | $6,030.91 | 2019-2025 | Watchman Flx, Farapulse, Rhythmia Mapping System |
| Biosense Webster, INC. | $5,111.69 | 2022-2025 | Carto 3, Qdot Micro Catheter, Octaray Mapping Catheter |
| Medical Device Business Services, INC. | $1,112.13 | 2023 | Carto 3 |
| Abbott Laboratories | $565.93 | 2022-2025 | Aveir, Agilis, Jot Dx |
| Pfizer INC. | $376.99 | 2021-2025 | |
| Impulse Dynamics (USA) INC. | $290.36 | 2023 | Optimizer |
| E.R. Squibb & Sons, L.L.C. | $273.86 | 2019-2025 | Camzyos, Eliquis |
| Atricure, INC. | $174.80 | 2023 | |
| Amgen INC. | $151.06 | 2019-2025 | Repatha, Repatha |
| Infobionic, INC | $141.19 | 2024 | Mome Device |
| Novo Nordisk INC | $106.95 | 2023-2025 | Wegovy, Ozempic |
| Irhythm Technologies, INC. | $83.94 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $80.84 | 2022-2023 | Lifevest |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $54.71 | 2022-2025 | Verquvo |
| Philips North America LLC | $46.90 | 2023-2024 | (Ck4) Mcot |
| Cordis US Corp. | $35.56 | 2025 | Mynx Control Venous |
| Angiodynamics, INC. | $31.27 | 2024 | Angiovac |
| B. Braun Interventional Systems INC. | $29.18 | 2023 | Spectraline Syringe |
| Genzyme Corporation | $22.51 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.03 | 2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $18.67 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $17.62 | 2023 | Andexxa |
| Stryker Corporation | $16.95 | 2023 | Stryker |
| Kiniksa Pharmaceuticals, LTD. | $16.82 | 2023 | Arcalyst |
| Vifor Pharma, INC. | $11.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rigoberto Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.